SELUX
DEAD

Serial Number

97620795

Owner

SeLux Diagnostics, Inc.

Attorney

Trevor A. Caudle, Esq.

First Use Date

Jun 22, 2018

Filing Date

Oct 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SELUX Trademark

Serial Number: 97620795

SELUX is a trademark filed by SeLux Diagnostics, Inc. on October 5, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SeLux Diagnostics, Inc. (14 trademarks)

Charlestown, MA 02129

Entity Type: 03

Trademark Details

Filing Date

October 5, 2022

Registration Date

Not Registered

First Use Anywhere

June 22, 2018

First Use in Commerce

June 22, 2018

Published for Opposition

June 11, 2024

Goods & Services

(Based on Intent to Use) Scientific instruments, namely, portable and benchtop imagers and analyzers in the nature of a fluorescence detector for analysis for use in the life science research field that use light scattering, microscopy, and downloadable and recorded image analysis software to detect, quantify, and bind biological or chemical molecules; diagnostic apparatus and instruments, not for medical use in the nature of laboratory equipment and devices used for manual and automated testing in industrial applications that isolate, identify, quantify, reveal, control, and detect contaminating substances, namely, for the analysis of an industrial sample, a cosmetic sample, or an environmental sample to determine contaminants, to determine composition, and to control quality; downloadable and recorded software used to process and interpret the results of industrial testing that isolates, identifies, quantifies, reveals, controls, and detects infectious disease contaminating substances

(Based on Intent to Use) Reagents for medical use; clinical medical reagents; diagnostic preparations for medical purposes; diagnostic test kits consisting primarily of medical diagnostic reagents, and also including chemical reagents for medical purposes, nucleic acid probes, antimicrobial agents for medical diagnoses, and containers for chemicals medical waste, for use in disease testing, microbial testing, and microorganism testing; reagents and cell culture and cell growth media for medical and veterinary diagnosis; diagnostic reagents for medical purposes

(Based on Intent to Use) Reagents for scientific or medical research use; diagnostic preparations for scientific or research use; chemicals for use in industry and science; chemicals for use in industry and science, namely, chemical solutions in the nature of chemicals for use in industry and science, reagents for research and diagnostic purposes, and diagnostic test kits consisting primarily of reagents for research and diagnostic purposes, test cards in the nature of chemical test panels being chemical test paper and also including applicator sticks being swabs for medical purposes to control and detect contaminating substances in industrial, agricultural, cosmetic, and pharmaceutical products for scientific or research use

(Based on Intent to Use) Medical diagnostic apparatus for analyzing and measuring bacteria in the body; apparatus and instruments for medical diagnosis of infectious diseases, namely, equipment and devices in the nature of immuno-analyzers, nucleic acid analyzers, bacteriologic analyzers, and microbiologic analyzers used for testing or for manual or for automated testing of pathogens in medical and clinical applications

(Based on Use in Commerce) Research and development services in the field of developing diagnostics for infectious diseases; (Based on Intent To Use) Providing temporary use of online non-downloadable software used to process and interpret the results of industrial testing that isolates, identifies, quantifies, reveals, controls, and detects infectious diseases and contaminating substances; Providing temporary use of online non-downloadable image analysis software to detect, quantify, and bind biological or chemical molecules

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 10, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 10, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 6, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2024 CNRT
EXAMINER'S AMENDMENT ENTERED
Mar 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 27, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 14, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 14, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 14, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2024 CRFA
ASSIGNED TO LIE
Jan 11, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 19, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 19, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2022 NWOS
NEW APPLICATION ENTERED
Oct 8, 2022 NWAP